1048 DEVELOPMENT AND INTERNAL VALIDATION OF NOMOGRAMS PREDICTING PROSTATE CANCER SPECIFIC SURVIVAL IN PATIENTS WITH HIGH RISK DISEASE. RESULTS OF A MULTI-INSTITUTIONAL ANALYSIS

MLA

A. Briganti, et al. “1048 Development and Internal Validation of Nomograms Predicting Prostate Cancer Specific Survival in Patients with High Risk Disease. Results of a Multi-Institutional Analysis.” European Urology Supplements, vol. 10, Mar. 2011, p. 324. EBSCOhost, https://doi.org/10.1016/s1569-9056(11)61028-2.

APA

A. Briganti, M. Spahn, S. Joniau, G. Marchioro, B. Tombal, H. Hsu, P. Bader, M. Graefen, A. Tizzani, P. Van Cangh, P. Gontero, & H. Van Poppel. (2011). 1048 Development and Internal Validation of Nomograms Predicting Prostate Cancer Specific Survival in Patients with High Risk Disease. Results of a Multi-Institutional Analysis. European Urology Supplements, 10, 324. https://doi.org/10.1016/s1569-9056(11)61028-2

Chicago

A. Briganti, M. Spahn, S. Joniau, G. Marchioro, B. Tombal, H. Hsu, P. Bader, et al. 2011. “1048 Development and Internal Validation of Nomograms Predicting Prostate Cancer Specific Survival in Patients with High Risk Disease. Results of a Multi-Institutional Analysis.” European Urology Supplements 10 (March): 324. doi:10.1016/s1569-9056(11)61028-2.